
Karyopharm (KPTI) Stock: Recent Sell-Off Hits A New Buy Target
Chawalit Banpot/iStock via Getty Images Karyopharm Therapeutics (NASDAQ:KPTI) has sustained its efforts in supporting XPOVIO’s growth, which has led to another quarter of significant growth in net product revenue growth. Karyopharm continued to maximize XPOVIO’s […]